• In an increasingly hot biotech market, protecting IP is key

    8 days ago - By Tech Crunch

    John Flavin
    Contributor
    Share on Twitter
    John Flavin is founder and CEO of Portal Innovations, LLC .
    More posts by this contributor 2021 should be a banner year for biotech startups that make smart choices early
    Kevin O'Connor
    Contributor
    Share on Twitter
    Kevin A. O'Connor, Ph.D., is a partner in the Intellectual Property practice group at Neal Gerber Eisenberg .
    After a record year for biotech investment in 2020 - during which the industry saw $28.5 billion invested across 1,073 deals - the market for new innovations remains strong. What's more, these innovations are increasingly coming...
    Read more ...